KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Charles River Laboratories International (CRL) Other Gross PP&E Adjustments (2016 - 2025)

Charles River Laboratories International has reported Other Gross PP&E Adjustments over the past 16 years, most recently at $3.2 billion for Q4 2025.

  • Quarterly results put Other Gross PP&E Adjustments at $3.2 billion for Q4 2025, up 19.75% from a year ago — trailing twelve months through Dec 2025 was $3.2 billion (up 19.75% YoY), and the annual figure for FY2025 was $3.2 billion, up 19.75%.
  • Other Gross PP&E Adjustments for Q4 2025 was $3.2 billion at Charles River Laboratories International, up from $2.7 billion in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for CRL hit a ceiling of $3.2 billion in Q4 2025 and a floor of -$408.5 million in Q2 2023.
  • Median Other Gross PP&E Adjustments over the past 5 years was $2.3 billion (2021), compared with a mean of $1.3 billion.
  • Biggest five-year swings in Other Gross PP&E Adjustments: tumbled 1106.04% in 2022 and later skyrocketed 824.26% in 2024.
  • Charles River Laboratories International's Other Gross PP&E Adjustments stood at $2.4 billion in 2021, then fell by 5.48% to $2.2 billion in 2022, then surged by 31.79% to $2.9 billion in 2023, then decreased by 10.18% to $2.6 billion in 2024, then increased by 19.75% to $3.2 billion in 2025.
  • The last three reported values for Other Gross PP&E Adjustments were $3.2 billion (Q4 2025), $2.7 billion (Q3 2025), and $2.7 billion (Q2 2025) per Business Quant data.